€
About Us
About Royal Sense
Vision & Values
Board of Directors
Quality
Our Offerings
Pharmaceuticals
IVD Products
Orthotics
Medical Devices
Sutures
Investors
Corporate Governance
Disclosure Under Regulation 46
Disclosure under Regulation 30
Annual Report of Subsidiary Company
Half Yearly Financials
Investor Contact
Board Meeting
2024-25
2025-26
Investor Contact
Quarterly Compliances
December-2024
June 2024
June 2025
March 2024
March 2025
September-2024
Financial Results
Investor Contact
DISCLOSURE UNDER REGULATION 30
INTIMATION UNDER REG 30
Investor Contact
INVESTOR GRIEVANCE REGULATION 13 (3)
Quarterly Compliances
Investor Contact
Shareholding Pattern
Disclosure under 30 of SEBI LODR
Annual Returns
Newspaper publication
Annual Reports
General Meetings
Merger
Media
Media Release
Announcements
Partner With Us
Career
Available Roles
Deceptive Hiring Practices
Contact Us
March 2024
Audited Financial Result-2024
Certificate 7(3) Royal Sense_March 2024
Closure of Trading Window
FINAL RECONCILLIATIONREPORT MARCH 2024
Half Yearly Financial Result-Sep-March-2024
No applicability certificate_24A_RSL
Non Applicability of CG
Reg 23(9)
Reg. 74(5)
Regulation 13(3)_31.03.2024
Regulation 40(9)
RPT-Disclosure
SDD Compliance Certificate
Shareholding Pattern
Effortless well-being
Prepared to handle an extensive
range of pharmaceutical & surgical supplies,
tools, equipment, and related items."
let's chat
STAY CONNECTED